{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:58:01Z","timestamp":1791352681288,"version":"4.3.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,10,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We provide evidence that arsenic trioxide (As2O3) targets the BCR-ABL oncoprotein via a novel mechanism involving p62\/SQSTM1-mediated localization of the oncoprotein to the autolysosomes and subsequent degradation mediated by the protease cathepsin B. Our studies demonstrate that inhibitors of autophagy or cathepsin B activity and\/or molecular targeting of p62\/SQSTM1, Atg7, or cathepsin B result in partial reversal of the suppressive effects of AS2O3 on BCR-ABL expressing leukemic progenitors, including primitive leukemic precursors from chronic myelogenous leukemia (CML) patients. Altogether, these findings indicate that autophagic degradation of BCR-ABL is critical for the induction of the antileukemic effects of As2O3 and raise the potential for future therapeutic approaches to target BCR-ABL expressing cells by modulating elements of the autophagic machinery to promote BCR-ABL degradation.<\/jats:p>","DOI":"10.1182\/blood-2012-01-402578","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T23:22:49Z","timestamp":1345159369000},"page":"3555-3562","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":127,"title":["Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide"],"prefix":"10.1182","volume":"120","author":[{"given":"Dennis J.","family":"Goussetis","sequence":"first","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Jesse Brown VA Hospital, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Gounaris","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Gastroenterology, Department of Medicine, Northwestern University Medical School, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wu","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Vakana","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bogyo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Altman","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Jesse Brown VA Hospital, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas C.","family":"Platanias","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and"},{"name":"Division of Hematology\/Oncology, Northwestern University Medical School, Chicago, IL;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Jesse Brown VA Hospital, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111809395771200_B1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment.","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2019111809395771200_B2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications.","volume":"10","author":"Yang","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"2019111809395771200_B3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","article-title":"Autophagy: a lysosomal degradation pathway with a central role in health and disease.","volume":"1793","author":"Eskelinen","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2019111809395771200_B4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1083\/jcb.147.2.435","article-title":"Formation process of autophagosome is traced with Apg8\/Aut7p in yeast.","volume":"147","author":"Kirisako","year":"1999","journal-title":"J Cell Biol"},{"issue":"4","key":"2019111809395771200_B5","first-page":"307","article-title":"Evidence for fusion between multilamellar endosomes and autophagosomes in HeLa cells.","volume":"72","author":"Lucocq","year":"1997","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"2019111809395771200_B6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1083\/jcb.110.6.1935","article-title":"Studies on the mechanisms of autophagy: maturation of the autophagic vacuole.","volume":"110","author":"Dunn","year":"1990","journal-title":"J Cell Biol"},{"issue":"Pt 2","key":"2019111809395771200_B7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1242\/jcs.064576","article-title":"The regulation of autophagy: unanswered questions.","volume":"124","author":"Chen","year":"2011","journal-title":"J Cell Sci"},{"key":"2019111809395771200_B8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.cdd.4401751","article-title":"Autophagy and signaling: their role in cell survival and cell death.","volume":"12","author":"Codogno","year":"2005","journal-title":"Cell Death Differ"},{"issue":"16","key":"2019111809395771200_B9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/onc.2010.561","article-title":"Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis.","volume":"30","author":"Altman","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"2019111809395771200_B10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.","volume":"119","author":"Bellodi","year":"2009","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111809395771200_B11","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/cdd.2008.107","article-title":"The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias.","volume":"15","author":"Kamitsuji","year":"2008","journal-title":"Cell Death Differ"},{"issue":"1","key":"2019111809395771200_B12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2019111809395771200_B13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.","volume":"112","author":"Qu","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111809395771200_B14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1666","article-title":"Autophagy: dual roles in life and death?","volume":"6","author":"Baehrecke","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2019111809395771200_B15","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription.","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"issue":"14","key":"2019111809395771200_B16","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide.","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"issue":"4-5","key":"2019111809395771200_B17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2010.04.001","article-title":"Arsenic trioxide: an old drug rediscovered.","volume":"24","author":"Emadi","year":"2010","journal-title":"Blood Rev"},{"issue":"28","key":"2019111809395771200_B18","doi-asserted-by":"crossref","first-page":"18583","DOI":"10.1074\/jbc.R900003200","article-title":"Biological responses to arsenic compounds.","volume":"284","author":"Platanias","year":"2009","journal-title":"J Biol Chem"},{"issue":"7198","key":"2019111809395771200_B19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells.","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"issue":"9","key":"2019111809395771200_B20","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0813142106","article-title":"A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR\/ABL-associated leukemia.","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111809395771200_B21","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2003-05-1412","article-title":"JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.","volume":"103","author":"Davison","year":"2004","journal-title":"Blood"},{"issue":"39","key":"2019111809395771200_B22","doi-asserted-by":"crossref","first-page":"29989","DOI":"10.1074\/jbc.M109.090530","article-title":"Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.","volume":"285","author":"Goussetis","year":"2010","journal-title":"J Biol Chem"},{"issue":"50","key":"2019111809395771200_B23","doi-asserted-by":"crossref","first-page":"21683","DOI":"10.1073\/pnas.1016311108","article-title":"As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.","volume":"107","author":"Mao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"2019111809395771200_B24","doi-asserted-by":"crossref","first-page":"22446","DOI":"10.1074\/jbc.M603111200","article-title":"Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.","volume":"281","author":"Kannan-Thulasiraman","year":"2006","journal-title":"J Biol Chem"},{"issue":"18","key":"2019111809395771200_B25","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.1074\/jbc.M708816200","article-title":"Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.","volume":"283","author":"Dolniak","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111809395771200_B26","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1074\/jbc.M705227200","article-title":"Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.","volume":"283","author":"Altman","year":"2008","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111809395771200_B27","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1128\/MCB.01537-08","article-title":"Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals.","volume":"29","author":"Kroczynska","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2019111809395771200_B28","first-page":"439","article-title":"A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.","volume":"61","author":"Paglin","year":"2001","journal-title":"Cancer Res"},{"key":"2019111809395771200_B29","first-page":"2103","article-title":"Induction of Autophagic Cell Death in Malignant Glioma Cells by Arsenic Trioxide.","volume":"63","author":"Kanzawa","year":"2003","journal-title":"Cancer Res"},{"issue":"12","key":"2019111809395771200_B30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/22.12.1077","article-title":"Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.","volume":"22","author":"McLean","year":"1974","journal-title":"J Histochem Cytochem"},{"key":"2019111809395771200_B31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0076-6879(08)03610-0","article-title":"Monitoring autophagy by electron microscopy in Mammalian cells.","volume":"452","author":"Yl\u00e4-Anttila","year":"2009","journal-title":"Methods Enzymol"},{"issue":"2","key":"2019111809395771200_B32","first-page":"101","article-title":"Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle).","volume":"1765","author":"Tardy","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2019111809395771200_B33","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1074\/jbc.M109.065813","article-title":"Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm.","volume":"285","author":"Ha","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111809395771200_B34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2009.233","article-title":"Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells.","volume":"24","author":"Puissant","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"2019111809395771200_B35","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.9.10.1773","article-title":"Arsenic trioxide.","volume":"9","author":"Litzow","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"2019111809395771200_B36","doi-asserted-by":"crossref","first-page":"260146","DOI":"10.1155\/2008\/260146","article-title":"Arsenic-based antineoplastic drugs and their mechanisms of action.","volume":"2008","author":"Ralph","year":"2008","journal-title":"Met Based Drugs"},{"key":"2019111809395771200_B37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.pharmtox.47.120505.105144","article-title":"Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity.","volume":"47","author":"Kumagai","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"19","key":"2019111809395771200_B38","doi-asserted-by":"crossref","first-page":"12886","DOI":"10.1074\/jbc.M806546200","article-title":"Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.","volume":"284","author":"Morales","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111809395771200_B39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins.","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2019111809395771200_B40","first-page":"1155","article-title":"Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.","volume":"2","author":"McCafferty-Grad","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"2019111809395771200_B41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jnci\/90.2.124","article-title":"Arsenic trioxide as an inducer of apoptosis and loss of PML\/RAR alpha protein in acute promyelocytic leukemia cells.","volume":"90","author":"Shao","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"2019111809395771200_B42","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1158\/0008-5472.CAN-06-1774","article-title":"Targeted degradation of the AML1\/MDS1\/EVI1 oncoprotein by arsenic trioxide.","volume":"66","author":"Shackelford","year":"2006","journal-title":"Cancer Res"},{"issue":"9","key":"2019111809395771200_B43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djr168","article-title":"Inducing indigestion: companies embrace autophagy inhibitors.","volume":"103","author":"Garber","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2019111809395771200_B44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"issue":"13","key":"2019111809395771200_B45","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.4161\/cc.8.13.8892","article-title":"NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets.","volume":"8","author":"Lamark","year":"2009","journal-title":"Cell Cycle"},{"issue":"33","key":"2019111809395771200_B46","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.","volume":"282","author":"Pankiv","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"2019111809395771200_B47","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood-2010-03-276477","article-title":"Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis.","volume":"117","author":"Sun","year":"2011","journal-title":"Blood"},{"issue":"37","key":"2019111809395771200_B48","doi-asserted-by":"crossref","first-page":"32313","DOI":"10.1074\/jbc.M111.249060","article-title":"Inhibition of protein-tyrosine phosphatase 1B (PTP1B) mediates ubiquitination and degradation of Bcr-Abl protein.","volume":"286","author":"Alvira","year":"2011","journal-title":"J Biol Chem"},{"issue":"13","key":"2019111809395771200_B49","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein.","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111809395771200_B50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4161\/auto.7.4.14397","article-title":"Autophagy regulates myeloid cell differentiation by p62\/SQSTM1-mediated degradation of PML-RARalpha oncoprotein.","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"issue":"1","key":"2019111809395771200_B51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer.","volume":"29","author":"Palermo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"2019111809395771200_B52","doi-asserted-by":"crossref","first-page":"e13731","DOI":"10.1371\/journal.pone.0013731","article-title":"Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K\/Akt pathway in gliomas.","volume":"5","author":"Malla","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"2019111809395771200_B53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/auto.6260","article-title":"Bcl-2 family members: dual regulators of apoptosis and autophagy.","volume":"4","author":"Levine","year":"2008","journal-title":"Autophagy"},{"issue":"5","key":"2019111809395771200_B54","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1074\/jbc.M008944200","article-title":"Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route.","volume":"276","author":"Stoka","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111809395771200_B55","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/0008-5472.CAN-09-3537","article-title":"Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62\/SQSTM1 expression and AMPK activation.","volume":"70","author":"Puissant","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"2019111809395771200_B56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/17\/3555\/1357840\/zh804312003555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/17\/3555\/1357840\/zh804312003555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:35:28Z","timestamp":1574073328000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/17\/3555\/30602\/Autophagic-degradation-of-the-BCRABL-oncoprotein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":56,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,10,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-402578","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}